Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check26 days agoChange DetectedThe website has updated its contact information and principal investigators, with a new version (v2.14.0) released, while removing previous entries and consolidating the format.SummaryDifference12%
- Check40 days agoChange DetectedNew estimated update dates have been added for late 2024 and mid-2025, while several October 2023 dates and a previous update notice have been removed.SummaryDifference1%
- Check55 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.